About 2 000 South African children will take part in a global Covid-19 vaccine trial, with the first child to be inoculated in Pretoria today.

Published on

10 September 2021

South Africa is one of five countries to participate in Sinovac’s CoronaVac trial. The global trial will enrol 14 000 children, aged between 6 months and 17 years. The COO of Numolux, acting on behalf of Sinovac, Anton Arendse, says the CoronaVac vaccine is safe and has been approved for use by SAHPRA. Phase 1 and 2 trials in China have shown CoronaVac is well-tolerated in children and adolescents aged 3-17 years and induces a strong immune response. SAHPRA and the World Health Organisation have approved the global trial.

Merentia Van Der Vent

Merentia joined the media world in 1996 and in 2001, she took her first steps in the broadcasting world. In her free time, she likes to go on adventures in the city. She also likes to learn new dances, not that she is any good at that.